| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 137.33M | 149.61M | 136.58M | 101.91M | 91.84M | 86.86M |
| Gross Profit | 85.40M | 96.15M | 94.70M | 95.17M | 88.41M | 78.63M |
| EBITDA | 19.00M | 32.10M | 34.30M | 39.91M | 37.26M | 28.13M |
| Net Income | 13.28M | 23.67M | 25.00M | 28.78M | 26.43M | 19.26M |
Balance Sheet | ||||||
| Total Assets | 2.70B | 2.78B | 2.71B | 2.65B | 2.42B | 2.28B |
| Cash, Cash Equivalents and Short-Term Investments | 361.26M | 468.77M | 620.84M | 688.46M | 819.01M | 663.15M |
| Total Debt | 52.66M | 118.52M | 40.80M | 105.76M | 25.54M | 11.11M |
| Total Liabilities | 2.45B | 2.56B | 2.52B | 2.48B | 2.21B | 2.08B |
| Stockholders Equity | 245.31M | 215.31M | 195.24M | 166.39M | 211.46M | 199.70M |
Cash Flow | ||||||
| Free Cash Flow | 32.39M | 26.19M | 30.42M | 34.62M | 35.09M | 27.79M |
| Operating Cash Flow | 35.40M | 29.82M | 30.88M | 35.05M | 35.46M | 28.66M |
| Investing Cash Flow | 96.65M | -57.72M | -82.38M | -252.62M | -242.48M | -495.85M |
| Financing Cash Flow | -104.84M | 38.10M | 32.48M | 246.46M | 125.47M | 453.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $251.05M | 9.65 | 11.95% | 3.76% | 17.97% | 68.34% | |
73 Outperform | $265.74M | 9.17 | 12.11% | 3.12% | 8.17% | 21.95% | |
73 Outperform | $317.17M | 17.59 | 8.27% | 2.71% | 7.29% | 33.75% | |
70 Neutral | $258.35M | 7.86 | 11.15% | 3.24% | 12.91% | 21.72% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $242.13M | 18.09 | 5.69% | 2.54% | -6.25% | -38.79% | |
55 Neutral | $265.16M | 30.96 | 2.25% | 3.69% | 9.90% | ― |
During the fourth quarter of 2025, Chemung Financial Corporation’s management plans to engage with institutional investors to discuss strategic initiatives and recent performance. The company has demonstrated robust financial health with a 6.3% increase in quarterly dividends and significant loan growth. The restructuring of its balance sheet, including the sale of low-yielding securities and the raising of subordinated debt, aims to enhance profitability and strengthen capital ratios. This strategic move is expected to improve the company’s earnings and market positioning, particularly in high-growth areas like Albany and Buffalo.
The most recent analyst rating on (CHMG) stock is a Hold with a $55.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.
Chemung Financial Corporation, headquartered in Elmira, New York, operates as a financial services holding company through its subsidiary, Chemung Canal Trust Company, providing community banking services and financial products. In its third-quarter earnings report for 2025, Chemung Financial Corporation reported a net income of $7.8 million, or $1.62 per share, marking a significant turnaround from the previous quarter’s net loss of $6.5 million. This improvement is attributed to strategic balance sheet repositioning efforts, which have enhanced net interest income and overall financial performance.
On September 5, 2025, Chemung Financial Corporation announced the retirement of Thomas W. Wirth as Executive Vice President of the Wealth Management Group, effective October 1, 2025. In response, Jeffrey P. Kenefick has been appointed as interim head while a search for a permanent successor is conducted. Mr. Wirth, who has been with the company since 1987, will continue to provide strategic support in a consulting capacity for six months, highlighting his significant contributions to the company’s success.
The most recent analyst rating on (CHMG) stock is a Buy with a $56.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.
In September 2025, Chemung Financial Corporation’s management plans to engage with institutional investors to discuss strategies and performance. The company has recently undertaken significant financial restructuring, including issuing $45 million in subordinated notes and selling $245.5 million in securities, resulting in a $17.5 million pre-tax loss. These moves aim to optimize the balance sheet, enhance profitability, and support growth strategies, potentially impacting stakeholders positively by improving capital ratios and expanding market presence.
The most recent analyst rating on (CHMG) stock is a Buy with a $56.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.
On August 19, 2025, Chemung Financial Corporation announced a dividend increase of $0.02 per share, resulting in a quarterly cash dividend of $0.34 per share, payable on October 1, 2025, to shareholders of record as of September 17, 2025. This marks the second dividend increase in 2025, representing a 6.3% rise over the previous quarter’s dividend and bringing the total increase for the year to 9.7%.
The most recent analyst rating on (CHMG) stock is a Buy with a $59.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.